Literature DB >> 18437084

Protective role of heme oxygenase-1 in pancreatic microcirculatory dysfunction after ischemia/reperfusion in rats.

Ernst von Dobschuetz1, Rene Schmidt, Moritz Scholtes, Oliver Thomusch, Christian I Schwer, Klaus K Geiger, Ulrich T Hopt, Benedikt H J Pannen.   

Abstract

OBJECTIVES: Microcirculatory derangements caused by ischemia and reperfusion (I/R) play a pivotal role in acute and graft pancreatitis. The inducible enzyme heme oxygenase 1 (HO-1) has been shown to decrease I/R injury by modulation of capillary perfusion in other organs. It was the aim of this study to evaluate the effect of HO-1 induction on pancreatic microcirculation after I/R.
METHODS: Rats were randomized into 4 groups: (1) sham controls; (2) 1-hour ischemia and 2-hour reperfusion (I/R); (3) I/R + cobalt protoporphyrin (CoPP), an HO-1 inducer; and (4) I/R + CoPP + tin protoporphyrin, an HO inhibitor. Functional capillary density (FCD) and leukocyte endothelium interaction were analyzed using intravital microscopy during reperfusion. Expression of HO-1 mRNA, HO-1 protein, and HO activity were assessed by Northern blot, Western blot, and an HO activity assay.
RESULTS: Functional capillary density decreased significantly in the I/R group as compared with sham controls. Cobalt protoporphyrin treatment increased FCD to control values. In contrast, HO inhibition in CoPP-pretreated animals lowered FCD and increased leukocyte endothelium interaction significantly. Cobalt protoporphyrin administration increased HO-1 mRNA, protein, and HO activity, whereas activity of the enzyme was reduced after injection of tin protoporphyrin.
CONCLUSIONS: Heme oxygenase 1 plays a beneficial role in pancreatic microcirculatory derangements after I/R. This could be of therapeutic relevance after pancreas transplantation and other forms of postischemic pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18437084     DOI: 10.1097/MPA.0b013e31815ceb0e

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  6 in total

Review 1.  Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.

Authors:  Vijith Vijayan; Sebastian Mueller; Eveline Baumgart-Vogt; Stephan Immenschuh
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

2.  Effects of intravenous administration of pentoxifylline in pancreatic ischaemia-reperfusion injury.

Authors:  Edmond Raymond Le Campion; Jose Jukemura; Ana Maria Coelho; Rosely Patzina; Luiz Augusto Carneiro D'Albuquerque
Journal:  HPB (Oxford)       Date:  2012-12-17       Impact factor: 3.647

3.  Genetic analyses of heme oxygenase 1 (HMOX1) in different forms of pancreatitis.

Authors:  Sebastian Weis; Moritz Jesinghaus; Peter Kovacs; Dorit Schleinitz; Robert Schober; Claudia Ruffert; Max Herms; Henning Wittenburg; Michael Stumvoll; Matthias Blüher; Robert Grützmann; Hans-Ulrich Schulz; Volker Keim; Joachim Mössner; Peter Bugert; Heiko Witt; Joost P H Drenth; Knut Krohn; Jonas Rosendahl
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

4.  Impact of immunosuppressive agents on the expression of indoleamine 2,3-dioxygenase, heme oxygenase-1 and interleukin-7 in mesangial cells.

Authors:  Guo-Biao Liang; Guang-Heng Luo; Ding-Su Bao; An-Jian Chen; Yong-Xiang Zhuang; Ya-Nan Guo; Xin Wang; Yuan-Liang Wang; Zong-Ping Chen; Yi-Ping Lu; You-Ping Li
Journal:  Mol Med Rep       Date:  2015-05-04       Impact factor: 2.952

5.  Islet endothelial activation and oxidative stress gene expression is reduced by IL-1Ra treatment in the type 2 diabetic GK rat.

Authors:  Grégory Lacraz; Marie-Hélène Giroix; Nadim Kassis; Josiane Coulaud; Anne Galinier; Christophe Noll; Mélanie Cornut; Fabien Schmidlin; Jean-Louis Paul; Nathalie Janel; Jean-Claude Irminger; Micheline Kergoat; Bernard Portha; Marc Y Donath; Jan A Ehses; Françoise Homo-Delarche
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

6.  HO-1 Protects against Hypoxia/Reoxygenation-Induced Mitochondrial Dysfunction in H9c2 Cardiomyocytes.

Authors:  Dongling Chen; Zhe Jin; Jingjing Zhang; Linlin Jiang; Kai Chen; Xianghu He; Yinwei Song; Jianjuan Ke; Yanlin Wang
Journal:  PLoS One       Date:  2016-05-03       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.